Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CELG

Celgene

$102.02

-2.8 (-2.67%)

15:04
01/18/18
01/18
15:04
01/18/18
15:04
Hot Stocks
Celgene drug granted FDA orphan designation for pediatric ulcerative colitis »

Celgene's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

AMGN

Amgen

$188.01

2.47 (1.33%)

, BAYRY

Bayer

$31.80

-0.16 (-0.50%)

07:10
01/18/18
01/18
07:10
01/18/18
07:10
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2018 ASCO…

AMGN

Amgen

$188.01

2.47 (1.33%)

BAYRY

Bayer

$31.80

-0.16 (-0.50%)

BLRX

BioLineRx

$1.06

-0.02 (-1.85%)

BMY

Bristol-Myers

$61.85

1.93 (3.22%)

CELG

Celgene

$102.02

-2.8 (-2.67%)

DNA

Bought by RHHBY

ESALY

Eisai

$57.29

-0.855 (-1.47%)

EXEL

Exelixis

$27.49

-2.16 (-7.29%)

HALO

Halozyme

$17.98

-1.76 (-8.92%)

INCY

Incyte

$90.31

-1.34 (-1.46%)

IPSEY

Ipsen

$34.14

2.95 (9.46%)

LXRX

Lexicon

$10.17

0.35 (3.56%)

MGNX

MacroGenics

$19.85

0.07 (0.35%)

MRK

Merck

$62.03

-0.04 (-0.06%)

NVS

Novartis

$86.88

0.15 (0.17%)

SNY

Sanofi

$44.60

-0.31 (-0.69%)

ONCY

Oncolytics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

  • 25

    Jan

  • 25

    Jan

  • 02

    Feb

  • 03

    Feb

  • 05

    Feb

  • 08

    Feb

  • 15

    Feb

  • 16

    Feb

  • 05

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 30

    Apr

  • 02

    May

  • 17

    May

  • 28

    May

  • 23

    Oct

JUNO

Juno Therapeutics

$69.25

23.65 (51.86%)

, CELG

Celgene

$102.02

-2.8 (-2.67%)

05:14
01/18/18
01/18
05:14
01/18/18
05:14
Downgrade
Juno Therapeutics, Celgene rating change at Citi »

Citi downgrades Juno to…

JUNO

Juno Therapeutics

$69.25

23.65 (51.86%)

CELG

Celgene

$102.02

-2.8 (-2.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

Yesterday
AAPL

Apple

$179.10

2.91 (1.65%)

, JUNO

Juno Therapeutics

$69.25

23.65 (51.86%)

16:25
01/17/18
01/17
16:25
01/17/18
16:25
General news
On The Fly: Top stock stories for Wednesday »

Stocks opened higher and…

AAPL

Apple

$179.10

2.91 (1.65%)

JUNO

Juno Therapeutics

$69.25

23.65 (51.86%)

CELG

Celgene

$102.02

-2.8 (-2.67%)

BLUE

bluebird bio

$175.25

11.9 (7.29%)

BLCM

Bellicum Pharmaceuticals

$8.45

-0.01 (-0.12%)

CLLS

Cellectis

$30.19

2.41 (8.68%)

BAC

Bank of America

$31.18

-0.06 (-0.19%)

GS

Goldman Sachs

$253.65

-4.81 (-1.86%)

BA

Boeing

$351.01

15.85 (4.73%)

ERJ

Embraer

$24.69

-0.09 (-0.36%)

GT

Goodyear Tire

$34.37

0.87 (2.60%)

PSTG

Pure Storage

$17.89

1.73 (10.71%)

F

Ford

$12.18

-0.92 (-7.02%)

FAST

Fastenal

$52.20

-3.24 (-5.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 18

    Jan

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 31

    Jan

  • 31

    Jan

  • 01

    Feb

  • 15

    Feb

  • 16

    Feb

  • 21

    Feb

  • 26

    Feb

  • 14

    Mar

  • 25

    Mar

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

, CELG

Celgene

$104.82

-1.18 (-1.11%)

13:42
01/17/18
01/17
13:42
01/17/18
13:42
Recommendations
Juno Therapeutics, Celgene analyst commentary at Cantor Fitzgerald »

Celgene acquisition of…

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

, CELG

Celgene

$104.82

-1.18 (-1.11%)

12:18
01/17/18
01/17
12:18
01/17/18
12:18
General news
On The Fly: Top stock stories at midday »

Stocks opened sharply…

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

BLUE

bluebird bio

$163.35

-7.35 (-4.31%)

CLLS

Cellectis

$27.78

-1.54 (-5.25%)

BLCM

Bellicum Pharmaceuticals

$8.46

-0.5 (-5.58%)

BAC

Bank of America

$31.10

-0.145 (-0.46%)

GS

Goldman Sachs

$253.49

-4.97 (-1.92%)

GT

Goodyear Tire

$33.50

-0.41 (-1.21%)

PSTG

Pure Storage

$17.87

1.71 (10.58%)

F

Ford

$12.23

-0.8684 (-6.63%)

FAST

Fastenal

$55.44

-0.15 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 18

    Jan

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 31

    Jan

  • 15

    Feb

  • 16

    Feb

  • 26

    Feb

  • 14

    Mar

  • 25

    Mar

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

, CELG

Celgene

$104.82

-1.18 (-1.11%)

10:43
01/17/18
01/17
10:43
01/17/18
10:43
Hot Stocks
Juno, CAR-T peers rise after report of potential Celgene deal »

Shares of Juno…

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

GILD

Gilead

$80.25

1.23 (1.56%)

BLUE

bluebird bio

$163.35

-7.35 (-4.31%)

BLCM

Bellicum Pharmaceuticals

$8.46

-0.5 (-5.58%)

CLLS

Cellectis

$27.78

-1.54 (-5.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 12

    Feb

  • 16

    Feb

  • 26

    Feb

  • 25

    Mar

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

, CELG

Celgene

$104.82

-1.18 (-1.11%)

07:42
01/17/18
01/17
07:42
01/17/18
07:42
Recommendations
Juno Therapeutics, Celgene analyst commentary at Wells Fargo »

Juno Therapeutics price…

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

ORCL

Oracle

$49.59

0.08 (0.16%)

, PBR

Petrobras

$11.70

0.23 (2.01%)

07:35
01/17/18
01/17
07:35
01/17/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

ORCL

Oracle

$49.59

0.08 (0.16%)

PBR

Petrobras

$11.70

0.23 (2.01%)

AMAT

Applied Materials

$54.50

1.05 (1.96%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

KMI

Kinder Morgan

$19.39

-0.13 (-0.67%)

KODK

Kodak

$8.50

-0.7 (-7.61%)

MGM

MGM Resorts

$36.03

1 (2.85%)

PX

Praxair

$162.10

-2.05 (-1.25%)

PVG

Pretium Resources

$11.65

0.5 (4.48%)

PAAS

Pan American Silver

$17.24

0.58 (3.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 21

    Feb

  • 25

    Mar

CELG

Celgene

$104.82

-1.18 (-1.11%)

, JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

05:45
01/17/18
01/17
05:45
01/17/18
05:45
Recommendations
Celgene, Juno Therapeutics analyst commentary at Jefferies »

Jefferies believes $8B…

CELG

Celgene

$104.82

-1.18 (-1.11%)

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.